Hypera (OTCMKTS:HYPMY) Share Price Passes Above Fifty Day Moving Average of $7.55
Hypera (OTCMKTS:HYPMY) Share Price Passes Above Fifty Day Moving Average of $7.55
Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $7.55 and traded as high as $8.33. Hypera shares last traded at $8.31, with a volume of 8,456 shares traded.
Hypera Stock Up 3.2 %
The firm has a market cap of $5.26 billion, a P/E ratio of 19.95 and a beta of 0.82. The business has a fifty day moving average of $7.55 and a 200 day moving average of $7.35.
Hypera Company Profile
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 8/8 – 8/12
- 2 Important Retail Stock Battles to Watch
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $7.55 and traded as high as $8.33. Hypera shares last traded at $8.31, with a volume of 8,456 shares traded.
Hypera S.A.(場外交易代碼：HYPMY-GET Rating)的股價在週五的交易中突破了50日移動均線。該股的50日移動均線為7.55美元，最高交易價格為8.33美元。Hypera的股票最新交易價格為8.31美元，成交量為8,456股。
Hypera Stock Up 3.2 %
Hypera股價上漲3.2%
The firm has a market cap of $5.26 billion, a P/E ratio of 19.95 and a beta of 0.82. The business has a fifty day moving average of $7.55 and a 200 day moving average of $7.35.
該公司市值為52.6億美元，市盈率為19.95倍，貝塔係數為0.82。該業務的50日移動均線切入位在7.55美元，200日移動均線切入位在7.35美元。
Hypera Company Profile
Hypera公司簡介
(Get Rating)
(獲取評級)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作為一家制藥公司運營。它提供的處方藥有Adacne、Addera、Apri、AmpliumG、請、賽萊他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、雙丙胺、雙丙沙星、雙丙鬆、雙丙鬆、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混懸劑、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 8/8 – 8/12
- 2 Important Retail Stock Battles to Watch
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
- 免費獲取StockNews.com關於Hypera的研究報告(HYPMY)
- MarketBeat：回顧中的一週2012-8-8
- 值得關注的兩場重要的零售股大戰
- 什麼是WallStreetBets，他們的目標是什麼股票？
- 機構和分析師推動Jack in the Box走高
- 你能猜到哪個電動車股票打敗了特斯拉嗎？
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Hypera Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Hypera和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧